CLINICAL_TRIALS
trial_result
· 2019-11-25
Clinical Trial Update: Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Summary
Phase 2 trial of Volixibat (SHP626) in adults with nonalcoholic steatohepatitis was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Non-Alcoholic Steatohepatitis | Phase 2 | Status: TERMINATED | Results posted: 2019-11-25